LIST OF TABLES
• TABLE 1 KEY HUMAN INSULIN DRUGS: YEAR OF PATENT EXPIRY................................................................................ 38
• TABLE 2
KEY HUMAN INSULIN THERAPIES UNDER PIPELINE DEVELOPMENT & COMMERCIALIZATION: 2005-2015............................................................................................................... 50
• TABLE 3 HUMAN INSULIN PIPELINE: MAJOR COMPANIES INVOLVED.......................................................................... 51
• TABLE 4 HUMAN INSULIN PIPELINE: STAGES OF CLINICAL TRIAL............................................................................... 52
• TABLE 5 GLOBAL HUMAN INSULIN MARKET SIZE, BY PRODUCT TYPE, 2013 – 2020( USD MILLION)............................................................................................................................... 57
• TABLE 6 HUMAN INSULIN DRUGS MARKET SIZE, BY REGION, 2013 – 2020( USD MILLION)........................................ 59
• TABLE 7 HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2013 – 2020( USD MILLION)............................................................................................................................... 60
• TABLE 8 GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY TYPE, 2013 – 2020( USD MILLION)............................................................................................................................... 62
• TABLE 9 GLOBAL INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY TYPE, 2013 – 2020( USD MILLION)............................................................................................................................... 63
• TABLE 10 INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY REGION, 2013 – 2020( USD MILLION)................... 64
• TABLE 11 LONG-ACTING INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY REGION, 2013 – 2020( USD MILLION).......................................................................................................... 65
• TABLE 12 RAPID-ACTING INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY REGION, 2013 – 2020( USD MILLION).......................................................................................................... 66
• TABLE 13 PREMIXED INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY REGION, 2013 – 2020( USD MILLION).......................................................................................................... 67
• TABLE 14 GLOBAL HUMAN INSULIN BIOLOGICS MARKET SIZE, BY TYPE, 2013 – 2020( USD MILLION)........................ 68
• TABLE 15 HUMAN INSULIN BIOLOGICS MARKET SIZE, BY REGION, 2013 – 2020( USD MILLION).................................. 69
• TABLE 16 SHORT-ACTING HUMAN INSULIN BIOLOGICS MARKET SIZE, BY REGION, 2013 – 2020( USD MILLION).......................................................................................................... 70
• TABLE 17 INTERMEDIATE-ACTING HUMAN INSULIN BIOLOGICS MARKET SIZE, BY REGION, 2013 – 2020( USD MILLION).......................................................................................................... 71
• TABLE 18 PREMIXED HUMAN INSULIN BIOLOGICS MARKET SIZE, BY REGION, 2013 – 2020( USD MILLION)............... 72
• TABLE 19 GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2013 – 2020( USD MILLION)............................................................................................. 74
• TABLE 20 GLOBAL INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY BRAND, 2013 – 2020( USD MILLION)........................................................................................................... 75
• TABLE 21 INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY REGION, 2013 – 2020( USD MILLION)................... 76
sales @ marketsandmarkets. com www. marketsandmarkets. com
18